financetom
Business
financetom
/
Business
/
LG Innotek to take stake in lidar maker Aeva as part of $50 million deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LG Innotek to take stake in lidar maker Aeva as part of $50 million deal
Jul 29, 2025 4:33 AM

SAN FRANCISCO, July 29 (Reuters) - Aeva Technologies ( AEVA )

said on Tuesday that South Korean camera module maker

LG Innotek will take an equity stake in Aeva ( AEVA ) as part

of a $50 million strategic collaboration.

Aeva ( AEVA ) makes lidar sensors that help vehicles and industrial

equipment gain a detailed three-dimensional view of their

environment and detect how fast surrounding objects are moving.

It supplies sensors to vehicle firms such as Daimler Truck and

industrial equipment makers such as Nikon.

As part of the deal, LG Innotek will make a $32 million equity

investment in Aeva ( AEVA ) for a "single-digit percentage ownership" in

the company, Aeva ( AEVA ) CEO Soroush Salehian told Reuters in an

interview.

The remainder of the deal will go toward building production

capacity for sensors that can go into robotics and consumer

devices, in addition to Aeva's ( AEVA ) existing markets of vehicles and

industrial equipment.

"The ultimate goal of this partnership is for LG Innotek and

Aeva ( AEVA ) to grow together as key players leading the next-generation

lidar market through a long-term technology partnership that

goes beyond the supply of products," the South Korean

electronics supplier's CEO, Hyuksoo Moon, said in a statement.

Salehian told Reuters that Aeva ( AEVA ) is working to integrate its

entire sensor into a single chip whose price can be driven low

enough to make it viable in consumer electronics such as

augmented reality headsets.

"The roadmap that we're going towards is double-digit

dollars," Salehian told Reuters. "We are already working towards

the next generation that will allow for a very low-cost

solution, which we think will be a game changer for mass

adoption of what we call precision sensing."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved